NextPlat Corp(NXPL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -3.7 | Insider Own | 63.48% | Shs Outstand | 2.7M | Perf Week | -4.76% |
| Market Cap | 0.02B | Forward P/E | 14.77 | EPS next Y | 171.76% | Insider Trans | - | Shs Float | 1.0M | Perf Month | -3.22% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.46 | Inst Own | 4.79% | Short Float | 0.33% | Perf Quarter | 46.5% |
| Income | -0.01B | P/S | 0.51 | EPS this Y | 80.73% | Inst Trans | -1.04% | Short Ratio | 0.08 | Perf Half Y | 65.93% |
| Sales | 0.05B | P/B | 1.48 | EPS next 5Y | - | ROA | -28.78% | Short Interest | 0.00M | Perf YTD | 68.73% |
| Book/sh | 6.07 | P/C | 2.05 | EPS past 3/5Y | 22.58% 46.76% | ROE | -43.1% | 52W High | -18.83% ($11.10) | Perf Year | 11.77% |
| Cash/sh | 4.4 | P/FCF | - | Sales past 3/5Y | 66.78% 57.03% | ROIC | -48.85% | 52W Low | 166.96% ($3.38) | Perf 3Y | -51.56% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 19.42% | Gross Margin | 4.28% | Volatility(W/M) | 2.81% 5.75% | Perf 5Y | -82.81% |
| Dividend TTM | - | EV/Sales | 0.29 | Sales Y/Y TTM | -17.82% | Oper. Margin | -13.8% | ATR (14) | 0.51 | Perf 10Y | -99.79% |
| Dividend Ex-Date | - | Quick Ratio | 1.92 | EPS Q/Q | 92.28% | Profit Margin | -20.38% | RSI (14) | 53.74 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.29 | Sales Q/Q | -10.26% | SMA20 | -1.87% ($9.18) | Beta | 1.9 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 2026/8/13 | SMA50 | 13.87% ($7.91) | Rel Volume | 0.16 | Prev Close | $9.05 |
| Employees | 130 | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | 76.19% 8.01% | SMA200 | 38.97% ($6.48) | Avg Volume(3M) | 0.04M | Price | $9.01 |
| IPO | 1999/3/15 | Option/Short | No/Yes | Trades | 81 | Volume | 6,336 | Change | -0.44% |
A small-cap company with a dual business structure that combines e-commerce distribution of satellite communications and IoT equipment with 340B pharmacy program and U.S. healthcare data management services. Its two main pillars are the sale of Iridium and Globalstar equipment and its 340B pharmacy program operations.
Over the past 1 year, roughly in the middle
19% below its 1-year high.
Traded less than usual That is 16% of its average volume.
NXPL has a sound balance sheet but weak earning power
Of every $100 in sales, $13.80 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +80.7% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $51. Peers typically go for $150.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -82.8%. The S&P 500 did +74% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 4.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #183 of 226 in the industry
Based on market cap of $24M.
FAQ
What kind of company is NXPL?
NXPL belongs to the Technology sector and operates in the Software - Application industry.
What is the market cap of NXPL?
The market cap of NXPL is approximately $24M, ranking 5,221 within its sector.
What is the 52-week high and low for NXPL?
NXPL has recorded a 52-week high of $11.10 and a low of $3.38.